Embold Health joined PBGH’s Data Demonstration Project, pairing cost transparency with physician-level quality data to define true healthcare value.

Quantum Health’s acquisition of Embold Health enhances AI-driven personalization and provider insights to deliver better care and client value.

Quantum Health and Embold Health unite to enhance AI-driven personalization, guiding members to high-value care and stronger ROI for clients.

Winner of the 2025 Health Value Award, Embold Health was honored for predictive analytics that enhance quality, lower costs, and improve care outcomes

In Healthcare IT Today, Dr. Daniel Stein shares how responsible AI helps employers guide members to trusted, high-quality care decisions.

At the 2025 Business Group on Health Conference, Embold, Microsoft, and Walmart shared how AI-powered navigation enhances benefits and outcomes.

With its new AI-powered Virtual Assistant, Embold Health delivers real-time, clinically validated provider guidance that simplifies care navigation.

At major 2024 healthcare conferences, Embold Health will share how our data-driven solutions guide members to the right care and better outcomes.

The Validation Institute has confirmed Embold's provider quality methodology as effective in improving outcomes, transparency, and lowering costs.

Embold Health’s AI-powered Provider Selector, integrated into Microsoft’s healthcare agent service, connects users to high-quality, affordable care.

Embold Health launched Embold Rewards, giving employees gift cards for choosing top-performing doctors, improving engagement, outcomes, and ROI.

Quantum Health and Embold Health joined forces to power Care Finder™ with quality data, guiding millions to better outcomes and affordable care.

Embold’s Steve Dufour and Mark Blackham joined the Deploy Securely podcast to share how Embold advances AI in healthcare with trust and accountability

Newsweek named Embold Health one of 2024’s top 50 U.S. digital health companies in Data Analytics, recognizing its data-driven innovation.

At its second annual Client Advisory Board, Embold collaborated with clients to exchange ideas and shape the next wave of healthcare innovation.

Embold Health named Al Codalbu and Alice Rawlings Williams to key sales leadership roles to strengthen employer strategy and expand nationwide.

Embold Health earned two new U.S. patents, strengthening its technology and advancing its mission to deliver physician-level insights for better care.

Dr. Daniel Stein and Morgan Health’s Rivka Friedman wrote in BenefitsPRO on how transparent quality data can cut costs and improve outcomes.

Dr. Daniel Stein joined the NEJM Catalyst podcast to discuss how Embold’s physician performance data helps employers improve care and lower costs.

Embold’s latest update adds Medicare data and expands to include nurse practitioners and physician assistants, now evaluating 528K+ providers.

On The Benefits Playbook, Embold CMO Dr. Matt Resnick shared how measuring care quality empowers employees and supports smarter employer plan design.

On the Listening In podcast, Embold CMO Dr. Matt Resnick explored how better quality measurement and evidence-based care improve access and outcomes.

Embold Health partners with ICUBA to deliver physician performance insights that improve care quality, reduce unnecessary costs, and empower members.

Through a partnership with The Leapfrog Group, Embold Health now features hospital safety grades to guide members to safer, higher-quality care.

Embold partnered with Polk County Public Schools to help more than 14,000 employees and families find top-performing doctors through Provider Guide.

Embold Health raised a Series B led by Echo Health Ventures to accelerate national expansion and advance its physician performance analytics platform.

Dr. Daniel Stein joined the DFW Business Group on Health Forum to share how data transparency drives better care and more affordable outcomes.

A joint study by Embold Health and JAMA Health Forum uncovered significant physician quality variation, emphasizing the value of transparent data.

At the 2021 Health Action Council conference, Embold leaders shared how data-driven insights help employers guide employees to high-quality care.

At the Florida Alliance Conference, Embold's Dr. Daniel Stein shared how quality data and benefit design work together to improve healthcare outcomes.

Embold President & Founder Dr. Daniel Stein spoke at the Business Group on Health Conference on how data transparency drives better, lower-cost care.

Walmart’s Lisa Woods and Embold's Daniel Stein spoke at ACHE on how provider-level data improves care quality, employee health, and outcomes.

At the Business Group on Health Annual Conference, Embold CEO Dr. Daniel Stein joined Walmart leaders to explore innovation through collaboration.

Through transparent performance data, Embold Health’s Provider Guide empowers employees to select top doctors for better results and reduced costs.

NEJM Catalyst spotlighted how employers can improve care quality, featuring Embold's data to reduce variation and guide employees to top doctors.

Dr. Matthew Resnick joined the I Don’t Care podcast to discuss how Embold’s physician ratings help patients find high-quality, affordable doctors.

Using trusted physician performance data, employers can lower costs, improve outcomes, and guide members to reliable, high-quality care.

In MedCity News, Embold's Dr. Matthew Resnick shared how evidence-based physician ratings promote transparency, quality, and improved outcomes.

Embold Health and SurgeryPlus® partnered to build a tiered network guiding members to top surgeons and physicians for high-quality, affordable care.

Through its expanded Walmart partnership, Embold Health now guides 215,000 associates and dependents across 11 markets to top-performing doctors.

CB Insights named Embold Health to its 2022 Digital Health 150 list for advancing physician performance analytics that enhance care and reduce costs.

Embold Health Founder Dr. Daniel Stein joins Senator Bill Frist on A Second Opinion to discuss quality transparency, performance, and better care.

Dr. Daniel Stein joined the Health & Veritas podcast to share how Embold uses real clinical data to rate physicians and improve healthcare quality.

Morgan Health invested $5M in Embold Health’s $23M Series B to expand access to physician quality data and improve care value.

Dr. Daniel Stein joined What’s the Future Health to discuss how data-driven physician ratings help employers improve care and lower overall costs.